Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery

NCT00119457 is registered in ClinicalTrials.gov with vTv Therapeutics as lead sponsor.

NCT NCT00119457
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00119457 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Placebo-Controlled Evaluation of the Safety and Efficacy of Three Weeks Extended VTE Prophylaxis With Daily Oral Doses of TTP889 After One Week of Standard Prophylactic Treatment Following Hip Fracture Surgery
Lead sponsor
vTv Therapeutics
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
April 30, 2006
Enrollment
300
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

embolism and thrombosis, hip fractures, venous thromboembolism